TIG Advisors’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
TIG Advisors's AMYT Position: Q2 2023 in Review
TIG Advisors sold out of Amryt Pharma (AMYT) in Q2 2023, closing a stake of 1,666,821 shares — an estimated $24.3M sold.
TIG Advisors first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $24.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.
- TIG Advisors reported no remaining Amryt Pharma position as of Q2 2023 after selling out during the quarter.
- TIG Advisors sold 1,666,821 Amryt Pharma shares in Q2 2023, an estimated $24.3M.
- TIG Advisors first reported a position in Amryt Pharma in Q1 2023 and held it in 1 quarter.
- TIG Advisors's Amryt Pharma position peaked at $24.3M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Amryt Pharma as of Q2 2023.
Based on TIG Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.